BioCatalystWatch
BBOTWorkspace / BBOT / OverviewCompany library
BridgeBio Oncology Therapeutics, Inc. logo

BridgeBio Oncology Therapeutics, Inc.

BridgeBio Oncology Therapeutics, Inc. (BBOT)

Website

Price
Market cap
Next catalystExpected Q4 2026BBO-10203 — BREAKER-101 · Phase 1 dataSEC filing ↗
Cash

Chart & Events

Candle interval

Core Clinical

BBO-10203

PI3Kα RAS-binding domain

PreINDP1P2P3FilingApproved
Upcoming / outlook

BBO-11818

Mutant KRAS (ON and OFF states)

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

BBO-8520

KRAS G12C (ON and OFF states)

PreINDP1P2P3FilingApproved
Upcoming / outlook

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

BBO-11818

Mutant KRAS (ON and OFF states)

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

BBO-10203

PI3Kα RAS-binding domain

PreINDP1P2P3FilingApproved
Upcoming / outlook

BBO-8520

KRAS G12C (ON and OFF states)

PreINDP1P2P3FilingApproved
Upcoming / outlook

Other pipelines

BBO-10203 + BBO-8520

PI3Kα RAS-binding domain + KRAS G12C (ON and OFF states)

PreINDP1P2P3FilingApproved
BBO-10203 + BBO-11818

PI3Kα RAS-binding domain + Mutant KRAS (ON and OFF states)

PreINDP1P2P3FilingApproved

Financial position

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Annual trends

Reported item

Reported shares and borrowings

Source and basis

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

BBOT PR & News

PR & News

BBOT SEC archive